Evaluating treatment of acute migraine with zavegepant 10 mg nasal spray
Recommended Citation
Lopez L. Evaluating treatment of acute migraine with zavegepant 10 mg nasal spray. Evidence-Based Practice. 2024;27(4):9-10. doi:10.1097/ebp.0000000000002013
Document Type
Article
Affiliations
Advocate Illinois Masonic Family Medicine Residency, Chicago, IL